Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumoursResearch in context by Chiel F. Ebbelaar, Anne M.L. Jansen, Leonie C.M. Speet, Frans Schutgens, Sietske Zoetemeyer, Anne-Marie Cleton-Jansen, Marijke R. van Dijk, Gerben E. Breimer, Lourens T. Bloem, Wendy W.J. de Leng, Remco van Doorn, Karijn P.M. Suijkerbuijk, Anne M.R. Schrader, Willeke A.M. Blokx

Get full text

Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma by Annegien Broeks, Michel W J M Wouters, Georgina V Long, Richard A Scolyer, Christian U Blank, Judith M Versluis, Karijn P M Suijkerbuijk, Petros Dimitriadis, Joyce Sanders, James S Wilmott, Alexander Maxwell Menzies, Yvonne M Schrage, Stephanie A Blankenstein, Robert Elens, Willeke A M Blokx, Winan van Houdt, Alexander C J van Akkooi

Get full text